HonorHealth Research Institute treats first patient in global trial targeting aggressive melanoma HonorHealth Research Institute recently treated the first patient in a 50-site international clinical trial that will test a new type of therapy aimed at difficult-to-treat melanoma, an aggressive type of skin cancer.
https://www.news-medical.net/n....ews/20250429/HonorHe